Eberhard Wieland is Professor of Clinical Chemistry and Laboratory Medicine . He is Medical Director and head of the Central Institute for Clinical Chemistry and Laboratory Medicine, Klinikum Stuttgart, Germany.
Dr. Wieland received his MD in Biochemistry from the Ruprecht-Karls-University, Heidelberg in 1982. Between 1983 and 1985 he was resident in Internal Medicine and received a training in Medical Microbiology at the University Hospital, Heidelberg.
In 1985 he was awarded a research fellowship by the Volkswagen foundation which he spent between 1985 and 1987 at the Department of Endocrinology and Metabolism of the University of California, San Diego, USA.
From 1987 to 1993 he received his training in Clinical Chemistry and Laboratory Medicine at the Georg-August-University Goettingen. In 1993 he was certified in Clinical Chemistry and became consultant in Laboratory Medicine. In 2000 he was appointed Professor of Clinical Chemistry.
Dr. Wieland became Medical Director and head of the Central Institute of Clinical Chemistry and Laboratory Medicine of Klinikum Stuttgart in 2003. He is teaching Clinical Chemistry and Laboratory Medicine at the Eberhard-Karls-University in Tuebingen.
Dr. Wieland conducts research in pharmacokinetics and pharamacodynamics of immunosupressant drugs. His current research interest is in biomarkers to complement TDM. In addition, he performs funded research on oxidative stress in transplantation medicine and atherosclerosis. Dr. Wieland has contributed over 90 articles for peer reviewed scientific journals and 16 book chapters on the topics TDM, atherosclerosis, oxidative stress and biomarkers. He has presented more than 160 lectures and posters at national and international events. He is an editorial board member of Clinical Biochemistry, Canada; Folia Medica Plovid, Bulgaria; and Journal of Laboratory Medicine, Germany. He is also an active referee for German accreditation bodies.